Multiple sclerosis with mite antigen-specific IgE

Jun-Ichi Kira, Yuji Kawano, Kenji Yamasaki

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

The total and mite astigen-specific IgE in the sera were measured in 60 patients with multiple sclerosis (MS) and 40 healthy controls by an enzyme- linked immunosorbent assay using two common mite antigens, Dermatophagoides farinae and Dermatophagoides pteronyssinus, in order to study the role of atopy in MS. Neither the total IgE level nor the frequency of mite antigen- specific IgE differed significantly between the MS patients (mean total IgE 162 U/ml, 42% mite IgE-positive) and healthy controls (mean total IgE 168 U/ml, 35% mite IgE-positive). The MS patients with mite antigen-specific IgE showed a significantly higher level of serum total IgE (mean 293 U/ml, P=0.0005) and a higher frequency of atopic disorders (36%, P=0.0508) than did the MS patients without mite antigen-specific IgE (mean total IgE 68 U/ml, atopic disorders 14%). The former group also showed a significantly higher frequency of male (P=0.0216), a younger age of onset (P=0.0081), a lower expanded disability status scale (EDSS) score (P=0.03) and a lower protein content in the cerebrospinal fluid (CSF) (P=0.0426) than the latter, while the duration of disease and a number of relapses did not differ significantly between the two groups. In addition, the mite IgE-positive MS showed a very low frequency of oligoclonal IgG bands in CSF (4%) and a significantly higher association of HLA-A24 (87.5%) than the healthy controls (45%). Therefore, the presence of IgE response to the mite antigens and atopy appeared to significantly lessen the severity of the disease and the immunologic abnormalities in MS.

Original languageEnglish
Pages (from-to)138-142
Number of pages5
JournalJournal of the Neurological Sciences
Volume157
Issue number2
DOIs
Publication statusPublished - May 7 1998

Fingerprint

Mites
Immunoglobulin E
Multiple Sclerosis
Antigens
Oligoclonal Bands
Cerebrospinal Fluid
HLA-A24 Antigen
Dermatophagoides pteronyssinus
Dermatophagoides Antigens
Immune System Diseases
Serum
Age of Onset
Enzyme-Linked Immunosorbent Assay

All Science Journal Classification (ASJC) codes

  • Neurology
  • Clinical Neurology

Cite this

Multiple sclerosis with mite antigen-specific IgE. / Kira, Jun-Ichi; Kawano, Yuji; Yamasaki, Kenji.

In: Journal of the Neurological Sciences, Vol. 157, No. 2, 07.05.1998, p. 138-142.

Research output: Contribution to journalArticle

Kira, Jun-Ichi ; Kawano, Yuji ; Yamasaki, Kenji. / Multiple sclerosis with mite antigen-specific IgE. In: Journal of the Neurological Sciences. 1998 ; Vol. 157, No. 2. pp. 138-142.
@article{5a94c7997b854945954b26de82e8b951,
title = "Multiple sclerosis with mite antigen-specific IgE",
abstract = "The total and mite astigen-specific IgE in the sera were measured in 60 patients with multiple sclerosis (MS) and 40 healthy controls by an enzyme- linked immunosorbent assay using two common mite antigens, Dermatophagoides farinae and Dermatophagoides pteronyssinus, in order to study the role of atopy in MS. Neither the total IgE level nor the frequency of mite antigen- specific IgE differed significantly between the MS patients (mean total IgE 162 U/ml, 42{\%} mite IgE-positive) and healthy controls (mean total IgE 168 U/ml, 35{\%} mite IgE-positive). The MS patients with mite antigen-specific IgE showed a significantly higher level of serum total IgE (mean 293 U/ml, P=0.0005) and a higher frequency of atopic disorders (36{\%}, P=0.0508) than did the MS patients without mite antigen-specific IgE (mean total IgE 68 U/ml, atopic disorders 14{\%}). The former group also showed a significantly higher frequency of male (P=0.0216), a younger age of onset (P=0.0081), a lower expanded disability status scale (EDSS) score (P=0.03) and a lower protein content in the cerebrospinal fluid (CSF) (P=0.0426) than the latter, while the duration of disease and a number of relapses did not differ significantly between the two groups. In addition, the mite IgE-positive MS showed a very low frequency of oligoclonal IgG bands in CSF (4{\%}) and a significantly higher association of HLA-A24 (87.5{\%}) than the healthy controls (45{\%}). Therefore, the presence of IgE response to the mite antigens and atopy appeared to significantly lessen the severity of the disease and the immunologic abnormalities in MS.",
author = "Jun-Ichi Kira and Yuji Kawano and Kenji Yamasaki",
year = "1998",
month = "5",
day = "7",
doi = "10.1016/S0022-510X(98)00025-2",
language = "English",
volume = "157",
pages = "138--142",
journal = "Journal of the Neurological Sciences",
issn = "0022-510X",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - Multiple sclerosis with mite antigen-specific IgE

AU - Kira, Jun-Ichi

AU - Kawano, Yuji

AU - Yamasaki, Kenji

PY - 1998/5/7

Y1 - 1998/5/7

N2 - The total and mite astigen-specific IgE in the sera were measured in 60 patients with multiple sclerosis (MS) and 40 healthy controls by an enzyme- linked immunosorbent assay using two common mite antigens, Dermatophagoides farinae and Dermatophagoides pteronyssinus, in order to study the role of atopy in MS. Neither the total IgE level nor the frequency of mite antigen- specific IgE differed significantly between the MS patients (mean total IgE 162 U/ml, 42% mite IgE-positive) and healthy controls (mean total IgE 168 U/ml, 35% mite IgE-positive). The MS patients with mite antigen-specific IgE showed a significantly higher level of serum total IgE (mean 293 U/ml, P=0.0005) and a higher frequency of atopic disorders (36%, P=0.0508) than did the MS patients without mite antigen-specific IgE (mean total IgE 68 U/ml, atopic disorders 14%). The former group also showed a significantly higher frequency of male (P=0.0216), a younger age of onset (P=0.0081), a lower expanded disability status scale (EDSS) score (P=0.03) and a lower protein content in the cerebrospinal fluid (CSF) (P=0.0426) than the latter, while the duration of disease and a number of relapses did not differ significantly between the two groups. In addition, the mite IgE-positive MS showed a very low frequency of oligoclonal IgG bands in CSF (4%) and a significantly higher association of HLA-A24 (87.5%) than the healthy controls (45%). Therefore, the presence of IgE response to the mite antigens and atopy appeared to significantly lessen the severity of the disease and the immunologic abnormalities in MS.

AB - The total and mite astigen-specific IgE in the sera were measured in 60 patients with multiple sclerosis (MS) and 40 healthy controls by an enzyme- linked immunosorbent assay using two common mite antigens, Dermatophagoides farinae and Dermatophagoides pteronyssinus, in order to study the role of atopy in MS. Neither the total IgE level nor the frequency of mite antigen- specific IgE differed significantly between the MS patients (mean total IgE 162 U/ml, 42% mite IgE-positive) and healthy controls (mean total IgE 168 U/ml, 35% mite IgE-positive). The MS patients with mite antigen-specific IgE showed a significantly higher level of serum total IgE (mean 293 U/ml, P=0.0005) and a higher frequency of atopic disorders (36%, P=0.0508) than did the MS patients without mite antigen-specific IgE (mean total IgE 68 U/ml, atopic disorders 14%). The former group also showed a significantly higher frequency of male (P=0.0216), a younger age of onset (P=0.0081), a lower expanded disability status scale (EDSS) score (P=0.03) and a lower protein content in the cerebrospinal fluid (CSF) (P=0.0426) than the latter, while the duration of disease and a number of relapses did not differ significantly between the two groups. In addition, the mite IgE-positive MS showed a very low frequency of oligoclonal IgG bands in CSF (4%) and a significantly higher association of HLA-A24 (87.5%) than the healthy controls (45%). Therefore, the presence of IgE response to the mite antigens and atopy appeared to significantly lessen the severity of the disease and the immunologic abnormalities in MS.

UR - http://www.scopus.com/inward/record.url?scp=0032493110&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032493110&partnerID=8YFLogxK

U2 - 10.1016/S0022-510X(98)00025-2

DO - 10.1016/S0022-510X(98)00025-2

M3 - Article

VL - 157

SP - 138

EP - 142

JO - Journal of the Neurological Sciences

JF - Journal of the Neurological Sciences

SN - 0022-510X

IS - 2

ER -